StockData
Veradermics, Inc logo

Veradermics, Inc (MANE) stock

MANENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$124.86−0.78 (-0.62%)

Close on Nov 18, 2026Market cap $5.22BP/E –Yield –

Veradermics net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -$70.00M.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$70.00M–
FY2024Dec 31, 2024-$26.49M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$23.50M–
Q1 FY2026Mar 31, 2026-$27.23M–
Q2 FY2025Jun 30, 2025-$15.65M–
Q1 FY2025Mar 31, 2025-$12.40M–

More Veradermics figures

See a number that looks wrong?